In the News
- 2024-2025 COVID-19 Vaccines Protected Against JN.1 Subvariants
- 2024-2025 COVID-19 Vaccines Effective Against JN.1 Subvariants
- How long does covid booster protection last? A new study offers answers.
- Other notable findings in JAMA Network
- New 2025 data shows COVID-19 vaccines provide effective, durable protection
- 2025 Data Confirms COVID-19 Vaccines Offer Strong and Lasting Protection
- Trump’s Picks for Top Health Jobs Not Just Team of Rivals but Team of Opponents
- Respiratory illness season is coming. Here are tips on staying healthy.
- Neue Corona-Varianten boomen – funktionieren Covid-Selbsttests noch?
- Hvem bør få oppfriskningsdose mot covid-19? Og når?
- Für wen lohnt sich der Covid-Booster noch?
- The Checkup With Dr. Wen: Here’s who needs to get the new covid shot now
- FDA approves the new Covid vaccine. Here’s the best time to get it.
- Nirmatrelvir/Ritonavir
- COVID is Surging Right Now. Here’s What Alarms Doctors the Most.
- How effective are COVID vaccines against current variants?
- Another COVID vaccine? Yes, and here’s why
- New ‘FLiRT’ COVID Variants Could Be Driving an Uptick in Cases. Here’s How to Avoid Them
- Current COVID boosters offer good protection against severe outcomes but less so against JN.1
- Study shows effectiveness of updated COVID-19 vaccines wanes moderately over time, is lower against circulating variants
- COVID Shots Could Use Another Update, Study Suggests
- COVID-19 vaccination and mortality in 2022. Risk of death from COVID-19 and other causes after COVID-19 vaccination in the Netherlands
- The National Immunization Program in the Netherlands. Surveillance and developments in 2022-2023
- COVID Update: The Pros and Cons of Paxlovid and Legevrio
- Paxlovid And Molnupiravir Reduce Mortality And Hospitalisation In High-Risk Omicron-Infected Patients
- Researchers debate effectiveness of Pfizer’s COVID-19 antiviral drug
- Paxlovid Works In The ‘Real World.’ Here’s How.
- Nirmatrelvir, Molnupiravir Use Lowers Risks for Omicron-Infected
- As Covid cases rise, what to know about Paxlovid
- Both Paxlovid, molnupiravir lower COVID Omicron deaths, hospitalizations, studies conclude
- Covid Drug Paxlovid Now Less Effective Than In Early Trials—But It’s Still Great At Preventing Death
- Paxlovid Is Now Less Effective Against Covid, Study Shows
- Are Paxlovid and Lagevrio Equals?
- Paxlovid and molnupiravir substantially reduced hospitalization and death from Omicron variants
- Paxlovid or Lagevrio use and severe outcomes from Omicron infections
- Using Metformin to Treat Patients With Post-COVID-19, Medical and Mental Conditions After Infection, and More
- COVID-19 mRNA Vaccines Destroy Your Immune System. Cleveland Clinic Proved It, But Negative Vaccine Efficacy Was Known as Early as Dec. 2021
- Pfizer, Moderna Vaccines Effective Against Omicron Infections in Children Younger Than 12
- MRNA vaccines efficacious against Omicron infections in children younger than 12
- Study yields important findings about COVID-19 vaccination and previous SARS-CoV-2 infection in children younger than 12 years
- COVID-19 vaccines protective in children ages 0 to 11
- MRNA Vaccines Efficacious Against Omicron Infections in Children Younger Than 12
- Effectiveness and Durability of Bivalent COVID-19 mRNA Vaccines
- Annex: Statement on the antigen composition of COVID-19 vaccines
- COVID-19 vaccines may undergo major overhaul this fall
- Why most Canadians don’t need another COVID-19 booster – at least not yet
- Studies show real-world usefulness of bivalent COVID boosters
- Durability of bivalent boosters against Omicron subvariants
- Bivalent Covid boosters ‘moderately durable’
- Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19
- Who Should Get a Covid Booster Now? New Data Offers Some Clarity.
- What’s next for COVID-19 vaccines? Scientists and regulators chart a course amid uncertainty
- Gillings study shows updated bivalent boosters are more effective at preventing hospitalization and death from omicron
- Two new studies paint encouraging picture of Covid-19 vaccine’s performance
- Covid Vaccines Targeting Omicron Should Be Standard, Panel Says
- Updated Booster Shots, Not Original COVID Vaccines, Should Be Standard: FDA Panel
- Study shows COVID-19 vaccines offer lasting protection
- COVID-19: mRNA vaccines provide durable protection against severe illness
- COVID-19 vaccines and therapeutics
- Study: Effectiveness of COVID-19 Vaccines Over 9 Months in NC
- We don’t need universal booster shots. We need to reach the unvaccinated.
- Vaccines provide ongoing prevention of hospitalisation and death – Large US study
- COVID19 vaccines offer lasting protection, claims study
- Study finds Moderna COVID vaccine efficacy peaks at 94% after 120 days
- Durability of mRNA-1273 Protection Against Symptomatic COVID-19 Examined
- Lin’s New England Journal of Medicine article makes case for children’s COVID-19 boosters
- Study finds Pfizer vaccine boosts, not destroys, immunity from past COVID-19 infection
- Fact Check-Vaccine-effectiveness study does not show ‘negative immunity’ or harm to the immune system
- NCDHHS announces availability of updated COVID-19 boosters, aims to combat new subvariants
- JAMA study shows COVID-19 vaccines, boosters and prior infection provide durable protection against severe outcomes of SARS-CoV-2 infection
- COVID-19 vaccines protect against severe outcomes but less so over time
- Primary vaccinations and boosters effective in reducing COVID-19 severity during Delta and Omicron predominance
- Huge Studies Evaluate COVID-19 Vaccines & Side Effects
- Impfungen, Booster und Genesung: Immunität gegen Corona stabil – mit Einschränkungen